Suppr超能文献

关于恰加斯病化疗的批判性综述。

A critical review on Chagas disease chemotherapy.

作者信息

Rodriques Coura José, de Castro Solange L

机构信息

Departamento de Medicina Tropical, Instituto Oswaldo Cruz-Fiocruz, Av. Brasil 4365, 21045-900 Rio de Janeiro, RJ, Brasil.

出版信息

Mem Inst Oswaldo Cruz. 2002 Jan;97(1):3-24. doi: 10.1590/s0074-02762002000100001.

Abstract

In this "Critical Review" we made a historical introduction of drugs assayed against Chagas disease beginning in 1912 with the works of Mayer and Rocha Lima up to the experimental use of nitrofurazone. In the beginning of the 70s, nifurtimox and benznidazole were introduced for clinical treatment, but results showed a great variability and there is still a controversy about their use for chronic cases. After the introduction of these nitroheterocycles only a few compounds were assayed in chagasic patients. The great advances in vector control in the South Cone countries, and the demonstration of parasite in chronic patients indicated the urgency to discuss the etiologic treatment during this phase, reinforcing the need to find drugs with more efficacy and less toxicity. We also review potential targets in the parasite and present a survey about new classes of synthetic and natural compounds studied after 1992/1993, with which we intend to give to the reader a general view about experimental studies in the area of the chemotherapy of Chagas disease, complementing the previous papers of Brener (1979) and De Castro (1993).

摘要

在这篇“批判性综述”中,我们对用于治疗恰加斯病的药物进行了历史介绍,时间跨度从1912年迈尔和罗查·利马的研究开始,直至硝呋烯腙的实验性应用。20世纪70年代初,硝呋替莫和苯硝唑被引入临床治疗,但结果显示差异很大,关于它们在慢性病例中的应用仍存在争议。在引入这些硝基杂环化合物后,仅有少数化合物在恰加斯病患者中进行了试验。南锥体国家在病媒控制方面取得了巨大进展,并且在慢性患者体内发现了寄生虫,这表明在此阶段讨论病因治疗的紧迫性,进一步凸显了寻找疗效更高、毒性更低药物的必要性。我们还综述了寄生虫的潜在靶点,并介绍了1992/1993年之后研究的新型合成和天然化合物,旨在让读者对恰加斯病化疗领域的实验研究有一个总体了解,作为对布雷纳(1979年)和德卡斯特罗(1993年)之前论文的补充。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验